Bioimplants or bio-implants are devices which are easily compatible with living tissues or organs within the body. The aging population and pressure to develop biocompatible implants with a long shelflife has brought evaluation of efficient and performance under question. The global bioimplants market report by Market Research Future (MRFR) covers developments of biomaterials, progress in manufacturing processes, and its scope for the period of 2018 to 2023 (forecast period).
Latest Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/6896
Bioimplants Market Scope
The global bioimplants market can
register 8.6% CAGR during the forecast period. It was valued at USD 98,350
million in 2017. Primary factors fueling market growth are bone degeneration
cases among the elderly, prevalence of lifestyle diseases such as diabetes,
infections, and others, and minimally invasive surgeries. Rise in research and
development activities and developments such as 3D printing, laser technology,
and nanotechnology can support market growth. Complex geometrical shapes of
bones and tailored requirements by patients designed for rehabilitation and
plastic surgeries can bode well for the market.
But unfavorable reimbursement policies,
high prices of implants, and lack of skilled personnel in handling surgeries
can hamper the growth of the global bioimplants market.
Segmentation
The global bioimplants market is
segmented by type, material, origin and end-user.
By type, the market is segmented into
ophthalmic implants, cardiovascular implant, orthopedic implants, dental
implants, spinal bio-implants, and others. The cardiovascular implant segment
comprises pacing devices, stents, and others. Dental implants are classified
into plate form dental implants and root form dental implants. While, the
spinal bioimplants segment is further segmented into motion preservation
implants, form dental implant, intervertebral spacers, and cervical implants.
Orthopedic Implants are divided into trauma implants, joint replacement
implants, orthobiologics, and knee replacement implants. Lastly, ophthalmic
implants are segmented into glaucoma implants and intraocular implants.
Materials within the market encompass
alloys, biomaterial metals, ceramics, and others. The biomaterial metals
segment comprises silver, titanium, gold, and platinum.
By origin, the market is segmented into
xenograft, autograft, allograft, and synthetic.
By end-user, the market is segmented
into specialty centers, hospitals, clinics, and others.
Regional Analysis
Geographically, the global bioimplants
market is segmented into the Americas, Europe, Asia Pacific (APAC), and the
Middle East & Africa (MEA).
The Americas are deemed to dominate the
global market owing to prevalence of chronic disorders such as diabetes and
obesity, incidence of chronic diseases, a large geriatric pool, and increasing
number of surgeries. According to the Centers for Disease Control &
Prevention (CDC), nearly 93 million Americans suffered from obesity. Large
number of hip and knee replacement surgeries is evidence of the large potential
of the market.
Europe is the second-largest region of
the market due to rise in research and development activities, occurrence of
orthopedic disorders, and ample funding for the healthcare sector. The large
number of cardiovascular disorder cases is giving prime impetus to the regional
bioimplants market growth. According to the European Heart Network, more than
85 million patients were diagnosed with some form of cardiovascular disease in
Europe in 2015.
APAC can display an exemplary growth
rate during the forecast period owing to rising investments in healthcare, rise
of disposable income levels, and a large geriatric population. According to the
United Nations ESCAP, the population of patients aged 60 and above can reach
1.3 billion by 2050. Alarming number of road accidents are likely to spur the
demand for bioimplants. This is supported by a report by Tokyo’s Keio
University stating the number of patients with spinal cord injuries to reach
100,000 in 2019.
The MEA can register the lowest growth
of the global bioimplants market due to lack of proper healthcare
infrastructure, paucity of technical knowledge, and an underdeveloped
healthcare sector.
Bioimplants Market Competitive Outlook
Integra LifeSciences, Stryker,
C.R.Bard, Inc., Wright Medical Group N.V., Invibio Ltd., Johnson & Johnson
Services, Inc., Abbott, Boston Scientific Corporation, Smith & Nephew plc,
Medtronic, Dentsply Sirona, Zimmer Biomet, and Cook Group are major players of
the global bioimplants market.
Read More About Bioimplants Market @ https://www.marketresearchfuture.com/reports/bioimplants-market-6896
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by Components, Application, Logistics and market
players for global, regional, and country level market segments, enable our
clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19
and its impact on various industry verticals and wherever required we will be
considering covid19 footprints for a better analysis of markets and industries.
Cordially get in touch for more details.
No comments:
Post a Comment